levodopa
chemical compound
Facts
20 properties- Instance of
- type of chemical entity
- Part of
- L-DOPA receptor activity, L-DOPA binding, L-dopa metabolic process, L-dopa biosynthetic process, response to L-dopa, cellular response to L-dopa[7][8][9][10][11][12]
- Has use
- medication[13]
- Canonical SMILES
- C1=CC(=C(C=C1CC(C(=O)O)N)O)O[3]
- Chemical formula
- C₉H₁₁NO₄[4]
- Defined daily dose
- 3.5 g
- Found in taxon
- Crataegus monogyna, Mucuna holtonii, Mucuna urens, Amanita muscaria, Ascophyllum nodosum, Astragalus hamosus, Crataegus oxyacantha L. (1753), Mucuna birdwoodiana, Mucuna interrupta, Mucuna macrocarpa, Mucuna lamellata, Mucuna sempervirens[14][15][16][17][18][19][20][21][22][23][24][25][26][27]
+10 more
Portulaca grandiflora, Stemonitis herbatica, Homo sapiens, Tenebrio molitor, Mucuna pruriens var. utilis, Mucuna pruriens, Musa cavendishii, Oryza molida, Crataegus laevigata, Broad Bean - Isomeric SMILES
- C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- MCN code
- 2922.50.31, 3003.90.45
- Mass
- 197.069 Da
- Medical condition treated
- Parkinson's disease (2003–present)
- Physically interacts with
- G protein-coupled receptor 143[2]
- Pregnancy category
- Australian pregnancy category B3, US pregnancy category C
- Significant drug interaction
- paliperidone, risperidone, droperidol, fluphenazine, (−)-selegiline, haloperidol, olanzapine, methyldopa, levomepromazine, periciazine, (RS)-sulpiride, chlorpromazine, rasagiline[28][29][30][31][32][33][34][35][36][37][38]
- Stereoisomer of
- D-dopa, L-dopa zwitterion
- Subject has role
- antiparkinson, dopaminergic, developmental toxicant (1999–present)
- Tautomer of
- L-dopa zwitterion
- World Health Organisation international non-proprietary name
- levodopa
🏷️ Also known as
en Levodopa
en Levodopum
en Sinemet®
en β-(3,4-dihydroxyphenyl)alanine
en β-(3,4-dihydroxyphenyl)-L-alanine
en L-beta-(3,4-Dihydroxyphenyl)alanine
en 3,4-dihydroxy-L-phenylalanine
en 3,4-Dihydroxy-L-phenylalanine
en 3-Hydroxy-L-tyrosine
en Dihydroxy-L-phenylalanine
en (−)-dopa
en L-3,4-dihydroxyphenylalanine
en (−)-3-(3,4-dihydroxyphenyl)-L-alanine
en L-dopa
en LDP540
en levodopa
ar ليفودوبا
de L-3,4-Dihydroxyphenylalanin
de L-Dopa
de Dopa
🔖 Identifiers · 59
- OpenAlex ID
- C2780304432
- A Dictionary of Biology ID
- 2476
- ATC code
- N04BA01
- Brockhaus Enzyklopädie online ID
- levodopa, l-dopa-biochemie
- CA PROP 65 ID
- levodopa
- CAS Registry Number
- 59-92-7
- ChEMBL ID
- CHEMBL1009
- ChemSpider ID
- 5824
- DSSTOX compound identifier
- DTXCID303209
- DSSTox substance ID
- DTXSID9023209
- DeCS ID
- 24230
Show all 59 identifiers +47
- DrugBank ID
- DB01235
- DrugCentral ID
- 1567
- EC number
- 200-445-2
- ECHA Substance Infocard ID
- 100.000.405
- Electronic Essential Medicines List medicine ID
- 411
- Elhuyar ZTH ID
- 027365
- Encyclopædia Britannica Online ID
- science/levodopa
- Freebase ID
- /m/03nl53
- Gmelin number
- 365846
- Gran Enciclopèdia Catalana ID
- levodopa
- Gran Enciclopèdia Catalana ID (former scheme)
- 0119241
- Guide to Pharmacology Ligand ID
- 3639
- HSDB ID
- 3348
- Human Metabolome Database ID
- HMDB0000181
- IEDB Epitope ID
- 150927
- InChI
- InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1
- InChIKey
- WTDRDQBEARUVNC-LURJTMIESA-N
- KEGG ID
- C00355
- KNApSAcK ID
- C00001357
- LiverTox ID
- LevodopaCarbodopa
- MassBank accession ID
- MSBNK-NAIST-KNA00173, MSBNK-NAIST-KNA00175, MSBNK-NAIST-KNA00284, MSBNK-NAIST-KNA00285, MSBNK-NAIST-KNA00576, MSBNK-NAIST-KNA00577, MSBNK-NAIST-KNA00578, MSBNK-NAIST-KNA00579, MSBNK-NAIST-KNA00684, MSBNK-NAIST-KNA00685, MSBNK-Osaka_Univ-OUF00206, MSBNK-RIKEN-PR010128, MSBNK-RIKEN-PR100091, MSBNK-RIKEN-PR100092, MSBNK-Kazusa-KZ000173
- MeSH concept ID
- M0012434
- MeSH descriptor ID
- D007980
- MeSH tree code
- D02.092.311.200.480, D02.455.426.559.389.657.166.175.200.480, D12.125.072.050.685.400.500, D12.125.072.050.875.130.500
- MedlinePlus drug identifier
- a619018
- Microsoft Academic ID (discontinued)
- 2780304432
- NALT ID
- 22978
- NDF-RT ID
- N0000146151
- NE.se ID
- levodopa
- PDB ligand ID
- DAH
- Probes And Drugs ID
- PD000068
- Quora topic ID
- L-dopa
- Reaxys registry number
- 2215169, 6060047
- RxNorm CUI
- 6375
- SPLASH
- splash10-0f6t-0911000000-796795c7db2b08bebd65, splash10-001i-0900000000-2c310034a1a871502b4c, splash10-0007-0970100000-0f747f49b6021ce91283, splash10-001i-0900000000-2183a68f58b951f3f1c7, splash10-0002-0729111000-9a2cd1c2347fa062b079, splash10-004i-0900000000-c8095a31ed4b3dbbc646, splash10-03di-0190000000-330b3c81e4279f2c12b0, splash10-0002-0900000000-efc5dfd988dedf39f4f8, splash10-0006-0502193020-497bfad7ba247159ca00, splash10-004i-0900000000-0b0d4b6dcb7f1fa24e1a, splash10-014i-0690000000-622497b3104c6082a45d, splash10-00xr-9350000000-b0cc4636931d2de64d81
+14 more
splash10-0002-0900000000-df116b84981cf4a1371a, splash10-0f6t-0900000000-1c1c39a8880442ea18df, splash10-0002-0900000000-a115045cfda5ed918bc4, splash10-0udi-0900000000-d11c32cf4edd5c61cbc1, splash10-0002-0900000000-983bcc6e878cf78ddda0, splash10-014i-1890000000-646d209fa1943582a336, splash10-014i-0690000000-720ed87e98a0d9f1721d, splash10-0uei-2900000000-501c8856e3516b98773c, splash10-0f8s-0900000000-70920dcbff18a08f8d3d, splash10-00e0-2900000000-dd5919e4a742c1089fca, splash10-056r-9300000000-a78b0b31dd33fe8479a7, splash10-014i-0590000000-4474e81e4226bb4e1d4c, splash10-0a59-2900000000-bf63b9b719959b82b543, splash10-0uea-0900000000-8eb71aa0cc8622f097a2 - SureChEMBL ID
- 22655
- Treccani's Dizionario di Medicina ID
- dopa
- UK Parliament thesaurus ID
- 418369
- UNII
- 46627O600J
- UNSPSC code
- 51142503
- WikiProjectMed ID
- L-DOPA
- World Health Organisation international non-proprietary name numeric ID
- 2651
🔗 Connections
Found in taxon 19
Significant drug interaction 14
← Significant drug interaction 14
Belongs to 2
Subject has role 2
← Drug or therapy used for treatment 2
Has use 1
Medical condition treated 1
Stereoisomer of 1
← Possible treatment 1
← Stereoisomer of 1
Press Enter · cited answer in seconds
0 sources
Summary
levodopa is a type of chemical entity[1].